Altered levels of serum sphingomyelin and ceramide containing distinct acyl chains in young obese adults

Enhanced Proinflammatory State and Autoimmune Activation: a Breakthrough to Understanding Chronic Diseases

(2014) Altan Onat et al.   CURRENT PHARMACEUTICAL DESIGN

Sphingomyelin Synthase 2 Activity and Liver Steatosis

(2013) Yue Li et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Pathological roles of ceramide and its metabolites in metabolic syndrome and Alzheimer's disease

(2013) Kohei Yuyama et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Serum total and high-density lipoprotein phospholipids: Independent predictive value for cardiometabolic risk

(2013) Altan Onat et al.   CLINICAL NUTRITION

Inhibition of ceramidede novosynthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease

(2013) Krzysztof Kurek et al.   LIVER INTERNATIONAL

Obesity and cancer risk: evidence, mechanisms, and recommendations

(2012) Ivana Vucenik et al.   Annals of the New York Academy of Sciences

Development of an enzymatic assay for sphingomyelin with rapid and automatable performances: Analysis in healthy subjects and coronary heart disease patients

(2012) Ryunosuke Ohkawa et al.   CLINICAL BIOCHEMISTRY

Ceramide kinase deficiency improves diet-induced obesity and insulin resistance

(2012) Susumu Mitsutake et al.   FEBS LETTERS

Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet

(2012) J T Brozinick et al.   INTERNATIONAL JOURNAL OF OBESITY

Role of ceramides in nonalcoholic fatty liver disease

(2012) Mangesh Pagadala et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

(2011) G. Vernon et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Dynamic Modification of Sphingomyelin in Lipid Microdomains Controls Development of Obesity, Fatty Liver, and Type 2 Diabetes

(2011) Susumu Mitsutake et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Impact of sphingomyelin levels on coronary heart disease and left ventricular systolic function in humans

(2011) Xueying Chen et al.   Nutrition & Metabolism

Inhibition of De Novo Ceramide Synthesis Reverses Diet-Induced Insulin Resistance and Enhances Whole-Body Oxygen Consumption

(2010) J. R. Ussher et al.   DIABETES

“Atherogenic index of plasma” (log10 triglyceride/high-density lipoprotein−cholesterol) predicts high blood pressure, diabetes, and vascular events

(2010) Altan Onat et al.   Journal of Clinical Lipidology

Blood sphingolipidomics in healthy humans: impact of sample collection methodology

(2010) Samar M. Hammad et al.   JOURNAL OF LIPID RESEARCH

Obesity: Genes, brain, gut, and environment

(2009) Undurti N. Das   NUTRITION

Why Young Adults Hold the Key to Assessing the Obesity Epidemic in Children

(2008) Joyce M. Lee   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Plasma Ceramides Are Elevated in Obese Subjects With Type 2 Diabetes and Correlate With the Severity of Insulin Resistance

(2008) J. M. Haus et al.   DIABETES

Principles of bioactive lipid signalling: lessons from sphingolipids

(2008) Yusuf A. Hannun et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Deregulation of sphingolipid metabolism in Alzheimer's disease

(2008) Xingxuan He et al.   NEUROBIOLOGY OF AGING